Last reviewed · How we verify

Sodium Fluoride (NaF)

GlaxoSmithKline · Phase 3 active Small molecule

Sodium fluoride strengthens tooth enamel and bone by incorporating fluoride ions into the mineral matrix, increasing resistance to demineralization and promoting remineralization.

Sodium fluoride strengthens tooth enamel and bone by incorporating fluoride ions into the mineral matrix, increasing resistance to demineralization and promoting remineralization. Used for Osteoporosis treatment and prevention, Dental caries prevention, Fluorosis management in endemic regions.

At a glance

Generic nameSodium Fluoride (NaF)
Also known asfluoride
SponsorGlaxoSmithKline
Drug classMineral supplement / Bone-active agent
TargetHydroxyapatite crystal structure; bacterial glycolytic enzymes
ModalitySmall molecule
Therapeutic areaDental health / Bone metabolism / Osteoporosis
PhasePhase 3

Mechanism of action

Fluoride ions substitute for hydroxyl groups in hydroxyapatite crystals of enamel and bone, creating fluorapatite, which is more resistant to acid attack and caries formation. This mechanism also enhances osteoblast activity and bone mineralization, making it useful in osteoporosis treatment. The fluoride ion directly inhibits glycolysis in cariogenic bacteria, providing an additional antimicrobial benefit.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results